Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease
Journal of Life Science and Applied Research · 2025
DOI: 10.4103/jlsar.jlsar_10_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Life Science and Applied Research, 2025. Verfasst von Robby Kumar und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sickle cell disease (SCD) is a group of genetic disorders characterized by the presence of an aberrant hemoglobin molecule, hemoglobin S. This leads to characteristic sickling of erythrocytes. In SCD, the sickled RBC clump together, causing vascular crisis, which is the most significant contributor to morbidity and mortality. This vascular complication causes a variety of manifestations such as vaso-occlusive crises, acute chest syndrome, stroke, and chronic organ damage. Early identification of SCD patients who are at risk for developing vascular complications is the most important preventive measure and management strategy for SCD. CD34 is a cell surface marker expressed on hematopoietic stem cells (HSC). CD34 is generally reported to decrease in vascular complication which caused complications. Thus, CD34 has emerged as a potential prognostic marker for vascular complications in SCD. This review aims to establish a link between progressive vascular complications in SCD and HSC.
Zitieren
APA
Kumar, R., Patanaik, Y. R., & Mohapatra, E. (2025). Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease. Journal of Life Science and Applied Research. https://doi.org/10.4103/jlsar.jlsar_10_25
Vancouver
Kumar R, Patanaik YR, Mohapatra E. Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease. Journal of Life Science and Applied Research. 2025. doi:10.4103/jlsar.jlsar_10_25
BibTeX
@article{Kumar2025,
author = {Kumar, Robby and Patanaik, Yash Raj and Mohapatra, Eli},
title = {Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease},
journal = {Journal of Life Science and Applied Research},
year = {2025},
doi = {10.4103/jlsar.jlsar_10_25}
}
EUVIMED